Products found to contain undeclared medicines
|
| |
| The United States: Reumofan Plus dietary supplement relabeled and sold as "WOW": contains undeclared drug ingredients dexamethasone, diclofenac sodium and methocrabamol |
| |
The U.S. Food and Drug Administration (FDA) is warning the public that the potentially harmful dietary supplement product Reumofan Plus is being relabeled and sold under the name "WOW". The product is being marketed to treat arthritis, muscle pain, osteoporosis, bone cancer, and other conditions. FDA laboratory analysis confirmed that "WOW" contains the same prescription drug ingredients that are in Reumofan Plus, including dexamethasone (a corticosteroid), diclofenac sodium (a non-steroidal anti-inflammatory drug), and methocrabamol (a muscle relaxant). These ingredients have the potential to cause serious injury. Consumers currently taking or who have taken Reumofan Plus or "WOW" should immediately consult a healthcare professional. Healthcare professionals are urged to ask their patients about the use of Reumofan Plus, "WOW", and other similar products marketed as dietary supplements when patients present with unexplained symptoms that suggest NSAID toxicity, psychiatric changes, or the use or abrupt discontinuation of corticosteroids.
Please refer to the following website in FDA for details:
http://www.fda.gov/Safety/MedWatch/../ucm332958.htm
In Hong Kong, the above products are not registered pharmaceutical products. Related news had been released by the FDA and UK MHRA and was posted on the website of Drug Office on 2 June, 22 August, 29 August 2012 and 18 October 2012.
Ends/ Thursday, December 20, 2012
Issued at HKT 12:30
|
| |
|
